Rafael Bejar is Sr. VP & Chief Medical Officer at Aptose Biosciences Inc. (APTO). They have made 1 open-market trade across 1 company since 2021, most recently 2023-01-19.
CIK 0001797382
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $26K since 2021, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| APTO | 110,000 | $188K |
Shares reported on the most recent Form 4, priced at the 2023-01-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APTO | BUY | 2021-11-19 | 2021-11-19 | $2.56 | $26K | -18.7% | -45.9% | -53.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.